Babson Capital Corporate Investors(MCI)

POST18.920.000.00%16:10 EDT

18.92-0.11-0.58%

CommunityCommunity
NewsNews
ProfileProfile
AnnouncementsAnnouncements

- Canada’s Drug Agency Issues Final Positive Recommendation Supporting Public Reimbursement of LEQEMBI® (lecanemab) for Early Alzheimer’s Disease
  GlobeNewswire · 09-01 07:30
  Canada’s Drug Agency Issues Final Positive Recommendation Supporting Public Reimbursement of LEQEMBI® (lecanemab) for Early Alzheimer’s Disease
- Barings Corporate Investors Q2 Net Investment Income Rises 1.7% to $6.26 Million
  Reuters · 08-29
  Barings Corporate Investors Q2 Net Investment Income Rises 1.7% to $6.26 Million
- Barings Names Brian Maute Head of U.S. Wealth Distribution
  Reuters · 08-24
  Barings Names Brian Maute Head of U.S. Wealth Distribution
- Barings Provides $72.6 Million Loan for 140 Kendrick Street Office Campus in Needham, Massachusetts
  Reuters · 08-24
  Barings Provides $72.6 Million Loan for 140 Kendrick Street Office Campus in Needham, Massachusetts
- LEQEMBI IQLIK® (lecanemab-irmb) Autoinjector for Initiation of Therapy Now Available in the U.S. for Early Alzheimer’s Disease
  GlobeNewswire · 08-24
  LEQEMBI IQLIK® (lecanemab-irmb) Autoinjector for Initiation of Therapy Now Available in the U.S. for Early Alzheimer’s Disease
- Barings Leads Senior Secured Credit Facilities Backing Edgewater Acquisition of Parker Manufacturing Group
  Reuters · 08-20
  Barings Leads Senior Secured Credit Facilities Backing Edgewater Acquisition of Parker Manufacturing Group
- Barings Names Imogen Harris Portfolio Manager for European Small and Mid-Cap Equities
  Reuters · 08-18
  Barings Names Imogen Harris Portfolio Manager for European Small and Mid-Cap Equities
- Canada's Clairvest Q1 Net Income Rises on Higher Private Equity Portfolio Valuations
  Reuters · 08-15
  Canada's Clairvest Q1 Net Income Rises on Higher Private Equity Portfolio Valuations
- Barings Leads Senior Secured Credit Facilities Backing Investcorp’s Acquisition of Berger Financial Group
  Reuters · 08-14
  Barings Leads Senior Secured Credit Facilities Backing Investcorp’s Acquisition of Berger Financial Group
- Sweden's Fram Skandinavien Q2 NAV Per Share Falls 7% Sequentially
  Reuters · 08-14
  Sweden's Fram Skandinavien Q2 NAV Per Share Falls 7% Sequentially
- Barings Corporate Investors Q2 NAV Rises, Declares Dividend
  Reuters · 08-14
  Barings Corporate Investors Q2 NAV Rises, Declares Dividend
- Barings Corporate Investors Q2 FY26 Net Increase in Net Assets Rises to $19.68 Million; Net Investment Income Holds at $6.26 Million
  Reuters · 08-14
  Barings Corporate Investors Q2 FY26 Net Increase in Net Assets Rises to $19.68 Million; Net Investment Income Holds at $6.26 Million
- Barings Corporate Investors Q2 Dividend USD 0.4
  THOMSON REUTERS · 08-14
  Barings Corporate Investors Q2 Dividend USD 0.4
- Barings Provides Senior Secured Credit Facilities Backing Thoma Bravo’s Acquisition of Padoa
  Reuters · 08-11
  Barings Provides Senior Secured Credit Facilities Backing Thoma Bravo’s Acquisition of Padoa
- Barings Provides $86.2 Million Acquisition Loan for Charleston Logistics Portfolio
  Reuters · 08-10
  Barings Provides $86.2 Million Acquisition Loan for Charleston Logistics Portfolio
- Barings CEO Mike Freno Says Firm Wins $2.1 Billion NCIA Mandate
  Reuters · 07-27
  Barings CEO Mike Freno Says Firm Wins $2.1 Billion NCIA Mandate
- Barings Serves as Agent on Senior Secured Credit Facilities for Quad-c’s Armstrong Transport Acquisition
  Reuters · 07-22
  Barings Serves as Agent on Senior Secured Credit Facilities for Quad-c’s Armstrong Transport Acquisition
- LEQEMBI® Real-World LEADER Study Presented at AAIC® 2026 Finds Over 75% of Early Alzheimer’s Patients Enrolled in the Study Remained Stable and Nearly 7% Improved Over an Average of 17 Months of Treatment
  GlobeNewswire · 07-14
  LEQEMBI® Real-World LEADER Study Presented at AAIC® 2026 Finds Over 75% of Early Alzheimer’s Patients Enrolled in the Study Remained Stable and Nearly 7% Improved Over an Average of 17 Months of Treatment
- FDA Approves LEQEMBI IQLIK® (lecanemab-irmb) Subcutaneous Injection as an Initiation Dose for Early Alzheimer’s Disease
  GlobeNewswire · 07-14
  FDA Approves LEQEMBI IQLIK® (lecanemab-irmb) Subcutaneous Injection as an Initiation Dose for Early Alzheimer’s Disease
- Barings leads senior secured credit facilities backing CIVC acquisition of Nationwide Legal Services
  Reuters · 06-22
  Barings leads senior secured credit facilities backing CIVC acquisition of Nationwide Legal Services
Company Profile
Company Name
Babson Capital Corporate Investors
Market
NYSE
Establishment Date
- -
Employees
- -
Office Location
- -
Website
http://www.barings.com
Zip Code
- -
Phone
- -
Fax
- -
Introduction
Babson Capital Corporate Investors trust is a closed ended fixed income mutual fund launched and managed by Barings LLC. It invests in fixed income markets of the United States. The fund seeks to invest in securities of companies operating across diversified sectors. It primarily invests in a portfolio of privately placed, below-investment grade, long term corporate debt obligations. The fund also invests in marketable investment grade debt securities, other marketable debt securities, and marketable common stocks. It was formerly known as Babson Capital Corporate Investors. Babson Capital Corporate Investors trust was formed in 1971 and is domiciled in the United States.
- 2023-12-01
  Correspondence
  Form CORRESP - Correspondence
  Form CORRESP - Correspondence
- 2023-02-14
  Beneficial Ownership Change
  SC 13G - Statement of acquisition of beneficial ownership by individuals
  SC 13G - Statement of acquisition of beneficial ownership by individuals
- 2020-02-14
  Beneficial Ownership Change
  [Amend] Statement of acquisition of beneficial ownership by individuals
  [Amend] Statement of acquisition of beneficial ownership by individuals
- 2019-08-16
  Statement Of Changes In Beneficial Ownership
  Statement of changes in beneficial ownership of securities
  Statement of changes in beneficial ownership of securities
- 2019-08-16
  Statement Of Changes In Beneficial Ownership
  Statement of changes in beneficial ownership of securities
  Statement of changes in beneficial ownership of securities
- 2019-08-16
  Statement Of Changes In Beneficial Ownership
  Statement of changes in beneficial ownership of securities
  Statement of changes in beneficial ownership of securities
- 2019-08-16
  Statement Of Changes In Beneficial Ownership
  Statement of changes in beneficial ownership of securities
  Statement of changes in beneficial ownership of securities
- 2019-08-06
  Statement Of Changes In Beneficial Ownership
  Statement of changes in beneficial ownership of securities
  Statement of changes in beneficial ownership of securities
- 2019-08-05
  Statement Of Changes In Beneficial Ownership
  Statement of changes in beneficial ownership of securities
  Statement of changes in beneficial ownership of securities
- 2019-08-05
  Statement Of Changes In Beneficial Ownership
  Statement of changes in beneficial ownership of securities
  Statement of changes in beneficial ownership of securities
- 2019-08-05
  Statement Of Changes In Beneficial Ownership
  Statement of changes in beneficial ownership of securities
  Statement of changes in beneficial ownership of securities
- 2019-08-05
  Statement Of Changes In Beneficial Ownership
  Statement of changes in beneficial ownership of securities
  Statement of changes in beneficial ownership of securities
- 2019-07-25
  Statement Of Changes In Beneficial Ownership
  Initial statement of beneficial ownership of securities
  Initial statement of beneficial ownership of securities
- 2019-07-19
  Statement Of Changes In Beneficial Ownership
  Statement of changes in beneficial ownership of securities
  Statement of changes in beneficial ownership of securities
- 2019-07-19
  Statement Of Changes In Beneficial Ownership
  Statement of changes in beneficial ownership of securities
  Statement of changes in beneficial ownership of securities

1D
5D
Day
Week
Month

Loading ...

High

19.34

Open

19.23

Volume%

0.36

Low

18.80

19.03

T/O Rate

0.18%

To The Moon

Babson Capital Corporate Investors(MCI)

Company Profile

Most Discussed